Publication: Management of malaria in Thailand.
| dc.contributor.author | Udomsak Silachamroon | en_US |
| dc.contributor.author | Srivicha Krudsood | en_US |
| dc.contributor.author | Nanthaphorn Phophak | en_US |
| dc.contributor.author | Sornchai Looareesuwan | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.date.accessioned | 2018-07-24T03:01:31Z | |
| dc.date.available | 2018-07-24T03:01:31Z | |
| dc.date.issued | 2002-01-01 | en_US |
| dc.description.abstract | The purpose of treatment for uncomplicated malaria is to produce a radical cure using the combination of: artesunate (4 mg/kg/day) plus mefloquine (8 mg/kg day) for 3 days: a fixed dose of artemether and lumefantrine (20/120 mg tablet) named Coartem (4 tablets twice a day for three days for adults weighing more than 35 kg): quinine 10 mg/kg 8-hourly plus tetracycline 250 mg 6-hourly for 7 days (or doxycycline 200 mg as an alternative to tetracycline once a day for 7 days) in patients aged 8 years and over: Malarone (in adult 4 tablets daily for 3 days). In treating severe malaria, early diagnosis and treatment with a potent antimalarial drug is recommended to save the patient's life. The antimalarial drugs of choice are: intravenous quinine or a parenteral form of an artemisinin derivative (artesunate i.v./i.m. for 2.4 mg/kg followed by 1.2 mg/kg injection at 12 and 24 hr and then daily for 5 dayss; artemether i.m. 3.2 mg/kg injection followed by 1.6 mg/kg at 12 and 24 hrs and then daily for 5 days; artemether i.m. (Artemotil) with the same dose of artemether or artesunate suppository (5 mg/kg) given rectally 12 hourly for 3 days. Oral artemisinin derivatives (artesunate, artemether, and dihydroartemisinin with 4 mg/kg/day) could replace parenteral forms when patients can tolerate oral medication. Oral mefloquine (25 mg/kg divided into two doses 8 hrs apart) should be given at the end of the artemisinin treatment course to reduce recrudescence. | en_US |
| dc.identifier.citation | The Korean journal of parasitology. Vol.40, No.1 (2002), 1-7 | en_US |
| dc.identifier.doi | 10.3347/kjp.2002.40.1.1 | en_US |
| dc.identifier.issn | 00234001 | en_US |
| dc.identifier.other | 2-s2.0-0036512099 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/20228 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0036512099&origin=inward | en_US |
| dc.subject | Immunology and Microbiology | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Management of malaria in Thailand. | en_US |
| dc.type | Review | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0036512099&origin=inward | en_US |
